Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial

BACKGROUND/AIMS: S-isomer (S) pantoprazole is more bioavailable and less dependent on cytochrome 2C19 than is racemic pantoprazole. We aim to evaluate the efficacy and safety of 10 mg S-pantoprazole for treatment of non-erosive reflux disease (NERD). METHODS: In this phase 3, double-blind, randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yu Kyung, Choi, Myung-Gyu, Park, Hyojin, Kim, Ji Won, Lee, Dong Ho, Ko, Kwang Hyun, Kim, Sang Gyun, Jung, Hwoon-Yong, Hong, Su Jin, Lee, Yong Chan, Lee, Si Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Neurogastroenterology and Motility 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026380/
https://www.ncbi.nlm.nih.gov/pubmed/33795542
http://dx.doi.org/10.5056/jnm19053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026380/
https://www.ncbi.nlm.nih.gov/pubmed/33795542
http://dx.doi.org/10.5056/jnm19053

Ejemplares similares